Currently, qRT‐PCR is used internationally as the gold standard for detecting BCR::ABL transcripts,15 and its detection results are used as important indicators for evaluating the efficacy and prognosis of patients with CML. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.